Tag: New leukemia drug is more effective and easier to use

New leukemia drug is more effective and easier to use

January 14, 2019

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging […]

Continue Reading